InDex Pharmaceuticals Holding
InDex Pharmaceuticals: USD50m deal with Viatris (Redeye)
2023-06-01 07:30
Redeye endorses yesterday evenings news that InDex Pharmaceuticals have entered into a USD50m licensing agreement with Viatris Japan to develop and commercialize cobitolimod in Japan. We leave our initial comments.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se